Limax Biosciences Overview

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $100K

  • Investors
  • 12

Limax Biosciences General Information

Description

Developer of a degradable adhesive hydrogel designed for hemostasis, wound closure, and drug delivery. The company's adhesive is stretchy and flexible, based on bio-inspired materials, to seal wounds and promote healing throughout the body, enabling healthcare professionals to utilize it in multiple indication areas.

Contact Information

Website
www.limaxbiosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building C, 240 Longwood Avenue
  • Boston, MA 02115
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Drug Delivery
Medical Supplies
Vertical(s)
Manufacturing, HealthTech, Life Sciences
Corporate Office
  • Building C, 240 Longwood Avenue
  • Boston, MA 02115
  • United States

Limax Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Limax Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Accelerator/Incubator 13-Aug-2026 $100K Completed Generating Revenue
12. Later Stage VC 11-Jul-2025 Completed Generating Revenue
11. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
10. Accelerator/Incubator 15-Mar-2023 Completed Generating Revenue
9. Accelerator/Incubator 14-Mar-2023 Completed Generating Revenue
8. Grant 29-Sep-2022 Completed Generating Revenue
7. Accelerator/Incubator 01-Jun-2022 Completed Generating Revenue
6. Grant 09-May-2022 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
4. Accelerator/Incubator 05-Oct-2021 Completed Generating Revenue
To view Limax Biosciences’s complete valuation and funding history, request access »

Limax Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Limax Biosciences Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
MassVentures Venture Capital Minority
Catalytic Impact Foundation Not-For-Profit Venture Capital Minority
Impact Assets Impact Investing Minority
The Biomimicry Institute Accelerator/Incubator
MassChallenge Accelerator/Incubator
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Limax Biosciences FAQs

  • Where is Limax Biosciences headquartered?

    Limax Biosciences is headquartered in Boston, MA.

  • What is the size of Limax Biosciences?

    Limax Biosciences has 10 total employees.

  • What industry is Limax Biosciences in?

    Limax Biosciences’s primary industry is Therapeutic Devices.

  • Is Limax Biosciences a private or public company?

    Limax Biosciences is a Private company.

  • What is Limax Biosciences’s current revenue?

    The current revenue for Limax Biosciences is .

  • How much funding has Limax Biosciences raised over time?

    Limax Biosciences has raised $115K.

  • Who are Limax Biosciences’s investors?

    MassVentures, Catalytic Impact Foundation, Impact Assets, The Biomimicry Institute, and MassChallenge are 5 of 12 investors who have invested in Limax Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process